Neutralizing Antibodies and Cytokines in Breast Milk After Coronavirus Disease 2019 (COVID-19) mRNA Vaccination

202155 citationsJournal Articlehybrid Open Access

Authors

Vignesh Narayanaswamy · Baystate Medical Center

Brian T. Pentecost · Twitter (United States)

Corina N. Schoen · Twitter (United States)

Dominique Alfandari · Twitter (United States)

Sallie S. Schneider · Twitter (United States)

Ryan Baker · Twitter (United States)

Kathleen F. Arcaro

Abstract

Humoral and cellular immune responses to mRNA-based COVID-19 vaccination are present in most women's breast milk. The milk anti-RBD antibodies can neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike and variants of concern. Anti-RBD antibodies are transferred to breastfed infants, with the potential to confer passive immunity against SARS-CoV-2.

Topics & Keywords

COVID-19 Impact on Reproduction Infant Nutrition and Health SARS-CoV-2 and COVID-19 Research

Publication Details

Published in: Obstetrics and Gynecology

Volume 139, Issue 2, pp. 181-191

DOI: 10.1097/aog.0000000000004661

Field-Weighted Citation Impact: 7.53

Command Palette

Neutralizing Antibodies and Cytokines in Breast Milk After Coronavirus Disease 2019 (COVID-19) mRNA Vaccination

Authors

Abstract

Topics & Keywords

Publication Details